Viewing Study NCT01777256


Ignite Creation Date: 2025-12-24 @ 11:14 PM
Ignite Modification Date: 2026-01-01 @ 8:12 AM
Study NCT ID: NCT01777256
Status: TERMINATED
Last Update Posted: 2017-04-26
First Post: 2013-01-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Adaptive Phase II Study to Evaluate the Efficacy, Pharmacodynamics, Safety and Tolerability of GSK2586184
Sponsor: GlaxoSmithKline
Organization: